Doherty James J.
President and CDO at ABOS
- Sold, on record
- $15k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Jan 8, 2026
- Form 144 notices
- 2
- Proposed sales
- Quarters with a sale
- 1 of the last 8
- 1 day with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- ABOSAcumen Pharmaceuticals, Inc.President and CDO
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- Jan 8, 2026No plan
Sold 13.1% of their holdings
$15k8,167 shares at $1.86
- Jan 8, 2026Notice
Filed a notice to sell 6,467 shares
$12k6,467 shares
- Jan 7, 2026Notice
Filed a notice to sell 1,700 shares
$3k1,700 shares
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Jan 21, 2026 | ABOS | President and CDO | AwardedEmployee Stock Option (right to buy) | 250,300 | 250,300 | SEC | ||
| Jan 16, 2026 | Jan 21, 2026 | ABOS | President and CDO | Awarded | 166,867 | 220,900 | SEC | ||
| Jan 8, 2026 | Jan 9, 2026 | ABOS | President and CDO | Sold | 8,167 | $1.86 | $15k | 54,033 | SEC |
| Jan 6, 2025 | Jan 7, 2025 | ABOS | President and CDO | AwardedEmployee Stock Option (right to buy) | 93,300 | 93,300 | SEC | ||
| Jan 6, 2025 | Jan 7, 2025 | ABOS | President and CDO | Awarded | 62,600 | 62,600 | SEC | ||
| Feb 1, 2024 | Feb 1, 2024 | ABOS | President and CDO | AwardedEmployee Stock Option (right to buy) | 601,000 | 601,000 | SEC |